Royal Bank of Canada’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Buy |
4,479
+4,410
| +6,391% | +$32.5K | ﹤0.01% | 5709 |
|
|
2025
Q1 | $1K | Sell |
69
-2,250
| -97% | -$32.6K | ﹤0.01% | 6251 |
|
|
2024
Q4 | $28K | Sell |
2,319
-3,216
| -58% | -$38.8K | ﹤0.01% | 5471 |
|
|
2024
Q3 | $92K | Buy |
5,535
+1,847
| +50% | +$30.7K | ﹤0.01% | 4947 |
|
|
2024
Q2 | $64K | Buy |
3,688
+3,108
| +536% | +$53.9K | ﹤0.01% | 5141 |
|
|
2024
Q1 | $10K | Sell |
580
-8,344
| -94% | -$144K | ﹤0.01% | 5742 |
|
|
2023
Q4 | $91K | Sell |
8,924
-832
| -9% | -$8.48K | ﹤0.01% | 5142 |
|
|
2023
Q3 | $88K | Buy |
9,756
+765
| +9% | +$6.9K | ﹤0.01% | 4979 |
|
|
2023
Q2 | $97K | Buy |
8,991
+7,492
| +500% | +$80.8K | ﹤0.01% | 4923 |
|
|
2023
Q1 | $15K | Sell |
1,499
-3,014
| -67% | -$30.2K | ﹤0.01% | 5747 |
|
|
2022
Q4 | $47K | Buy |
4,513
+4,136
| +1,097% | +$43.1K | ﹤0.01% | 5446 |
|
|
2022
Q3 | $5K | Sell |
377
-198
| -34% | -$2.63K | ﹤0.01% | 6223 |
|
|
2022
Q2 | $7K | Sell |
575
-2,172
| -79% | -$26.4K | ﹤0.01% | 6041 |
|
|
2022
Q1 | $29K | Sell |
2,747
-3,781
| -58% | -$39.9K | ﹤0.01% | 5910 |
|
|
2021
Q4 | $101K | Buy |
6,528
+3,718
| +132% | +$57.5K | ﹤0.01% | 5396 |
|
|
2021
Q3 | $64K | Buy |
2,810
+1,903
| +210% | +$43.3K | ﹤0.01% | 5492 |
|
|
2021
Q2 | $23K | Sell |
907
-351
| -28% | -$8.9K | ﹤0.01% | 5992 |
|
|
2021
Q1 | $52K | Buy |
+1,258
| New | +$52K | ﹤0.01% | 5358 |
|